Studies have shown that PD-L1 inhibitors cause a higher incidence of hyperthyroidism and hypothyroidism than PD-1 inhibitors, and combination therapy can lead to an increased incidence of thyroid dysfunction 95, 96. Here, CD274 is linked to hypothyroidism.